Literature DB >> 7561211

Viremia, fecal shedding, and IgM and IgG responses in patients with hepatitis E.

E T Clayson1, K S Myint, R Snitbhan, D W Vaughn, B L Innis, L Chan, P Cheung, M P Shrestha.   

Abstract

Viremia, fecal shedding and antibody responses to hepatitis E virus (HEV) infections are poorly understood. To better characterize HEV infections, these responses were examined in 67 patients with acute markers for hepatitis E who were admitted to the Infectious Disease Hospital in Kathmandu, Nepal in 1993. A single stool and multiple sera from each patient were examined using polymerase chain reaction to detect HEV RNA. Sera were also examined for antibodies to HEV. Viremia, fecal shedding, and IgM and IgG to HEV were detected in 93%, 70%, 79%, and 87% of 67 patients, respectively. Viremia or fecal shedding (or both) were detected in 14 patients from whom IgM and IgG to HEV were not detected. Viremia lasted at least 2 weeks in nearly all subjects and at least 39 days in 1 subject. Our results suggest that viremia is a common occurrence in patients infected with HEV.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7561211     DOI: 10.1093/infdis/172.4.927

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  39 in total

Review 1.  Adaptive Immune Responses in Hepatitis A Virus and Hepatitis E Virus Infections.

Authors:  Christopher M Walker
Journal:  Cold Spring Harb Perspect Med       Date:  2019-09-03       Impact factor: 6.915

2.  HAV and HEV infection in hospitalised hepatitis patients in Alexandria, Egypt.

Authors:  M Divizia; R Gabrieli; M L Stefanoni; E Renganathan; E El Ghazzawi; O A Kader; F Gamil; G El Sawaf; E El Sherbini; E Saleh; A M Degener; A Noce; L Zaratti; A Modesti; A Panà
Journal:  Eur J Epidemiol       Date:  1999-08       Impact factor: 8.082

Review 3.  Hepatitis e and acute liver failure in pregnancy.

Authors:  Subrat K Acharya
Journal:  J Clin Exp Hepatol       Date:  2013-09-05

4.  Detection of sporadic cases of hepatitis E virus (HEV) infection in China using immunoassays based on recombinant open reading frame 2 and 3 polypeptides from HEV genotype 4.

Authors:  Y Wang; H Zhang; Z Li; W Gu; H Lan; W Hao; R Ling; H Li; T J Harrison
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

5.  Quantitation of immunoglobulin to hepatitis E virus by enzyme immunoassay.

Authors:  Bruce L Innis; Jitvimol Seriwatana; Robin A Robinson; Mrigendra P Shrestha; Patrice O Yarbough; Charles F Longer; Robert M Scott; David W Vaughn; Khin Saw Aye Myint
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

6.  Hepatitis E Virus Genotype 3 Genomes from RNA-Positive but Serologically Negative Plasma Donors Have CUG as the Start Codon for ORF3.

Authors:  Heléne Norder; Cristina Galli; Ellen Magnil; Per Sikora; Elisabet Ekvärn; Kristina Nyström; Lars O Magnius
Journal:  Intervirology       Date:  2018-10-02       Impact factor: 1.763

7.  Probable transmission of hepatitis E virus (HEV) via transfusion in the United States.

Authors:  John R Ticehurst; Nora Pisanic; Michael S Forman; Carly Ordak; Christopher D Heaney; Edgar Ong; Jeffrey M Linnen; Paul M Ness; Nan Guo; Hua Shan; Kenrad E Nelson
Journal:  Transfusion       Date:  2019-01-31       Impact factor: 3.157

8.  Clinical and epidemiological relevance of quantitating hepatitis E virus-specific immunoglobulin M.

Authors:  Jitvimol Seriwatana; Mrigendra P Shrestha; Robert M Scott; Sergei A Tsarev; David W Vaughn; Khin Saw Aye Myint; Bruce L Innis
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

Review 9.  [Hepatitis as a travel disease].

Authors:  J Hadem; H Wedemeyer; M P Manns
Journal:  Internist (Berl)       Date:  2004-06       Impact factor: 0.743

10.  HEV infection as an aetiologic factor for acute hepatitis: experience from a tertiary hospital in Bangladesh.

Authors:  Salimur Rahman; Mobin Khan; Fazal Karim
Journal:  J Health Popul Nutr       Date:  2009-02       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.